Status:

RECRUITING

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach

Lead Sponsor:

Gustave Roussy, Cancer Campus, Grand Paris

Conditions:

Cancer

Eligibility:

All Genders

Brief Summary

Multicentric prospective study with collection of biological samples as part of type II research

Eligibility Criteria

Inclusion Criteria:

  • Patient with cancer who will start treatment anticancer (see cohorts).
  • Patient information and signature of the consent form before any specific procedure for the study. The patient must be able and must be inclined to cooperate in the study procedures.
  • Patient affiliated to a social security scheme or beneficiary of a similar scheme.

Exclusion Criteria:

  • Pregnant or lactating woman
  • Patient under guardianship or curatorship or deprived of liberty by a decision judicial or administrative or patient unable to give his consent.

Key Trial Info

Start Date :

January 22 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

1100 Patients enrolled

Trial Details

Trial ID

NCT04567446

Start Date

January 22 2018

End Date

December 1 2024

Last Update

June 12 2024

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Gustave Roussy

Villejuif, Val De Marne, France, 94800

2

Centre hospitalier du Pays d'Aix

Aix-en-Provence, France, 13616

3

Centre Pierre Curie

Beuvry, France, 62660

4

Clinique du Flandre

Coudekerque-Branche, France, 59210

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach | DecenTrialz